Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profileMean change in UAS7 ...

Navtemadlin is under clinical development by Kartos Therapeutics and currently in Phase III for Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis). According to GlobalData, Phase III drugs for ...

Participants’ body fat levels did not significantly influence this outcome, indicating that a healthy diet may directly and independently aid in managing chronic pain. Experts recommend adding ...

Chronic migraine becomes “refractory” when preventive treatments don’t work to reduce the frequency of episodes. Treatment may include complementary therapies like neuromodulation. Migraine ...

Conclusion: Treating chronic idiopathic urticaria with levocetirizine is a dominant strategy for society since it is more effective (in terms of pruritus-free days gained) and less costly than ...

If chronic kidney disease (CKD) is left untreated, it can lead to complications like anemia and high blood pressure, which can worsen kidney function and contribute to other health issues.

The biotech had previously been testing the oral itch medication in individuals with advanced chronic kidney disease ... which is in a phase 2 trial for idiopathic pulmonary fibrosis and a ...

How would you manage her leg symptoms? Chronic venous insufficiency manifests as a spectrum of signs and symptoms, including varicose veins, leg swelling, skin changes, and leg ulcers. The ...

‘Idiopathic’ means that it has no known cause. IPF is the most common form of pulmonary fibrosis and is a serious, chronic condition. Study finds high rate of lung damage in Indians after ...

“It is a chronic, progressive lung disease characterised by scarring (fibrosis) of the lung tissue, leading to irreversible loss of lung function. The exact cause of IPF is unknown, so it is termed ...

“It is a chronic, progressive lung disease characterised by scarring (fibrosis) of the lung tissue, leading to irreversible loss of lung function. The exact cause of IPF is unknown, so it is termed ...